Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study
- PMID: 30039175
- PMCID: PMC6248112
- DOI: 10.1001/jamaneurol.2018.1935
Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study
Abstract
Importance: The incidence of epilepsy is higher in older age than at any other period of life. Stroke, dementia, and hypertension are associated with late-onset epilepsy; however, the role of other vascular and lifestyle factors remains unclear.
Objective: To identify midlife vascular and lifestyle risk factors for late-onset epilepsy.
Design, setting, and participants: The Atherosclerosis Risk in Communities (ARIC) study is a prospective cohort study of 15 792 participants followed up since 1987 to 1989 with in-person visits, telephone calls, and surveillance of hospitalizations (10 974 invited without completing enrollment). The ARIC is a multicenter study with participants selected from 4 US communities. This study included 10 420 black or white participants from ARIC with at least 2 years of Medicare fee-for-service coverage and without missing baseline data. Data were analyzed betweeen April 2017 and May 2018.
Exposures: Demographic, vascular, lifestyle, and other possible epilepsy risk factors measured at baseline (age 45-64 years) were evaluated in multivariable survival models including demographics, vascular risk factors, and lifestyle risk factors.
Main outcomes and measures: Time to development of late-onset epilepsy (2 or more International Classification of Diseases, Ninth Revision codes for epilepsy or seizures starting at 60 years or older in any claim [hospitalization or outpatient Medicare through 2013]), with first code for seizures after at least 2 years without code for seizures.
Results: Of the 10 420 total participants (5878 women [56.4%] and 2794 black participants [26.8%]; median age 55 years at first visit), 596 participants developed late-onset epilepsy (3.33 per 1000 person-years). The incidence was higher in black than in white participants (4.71; 95% CI, 4.12-5.40 vs 2.88; 95% CI, 2.60-3.18 per 1000 person-years). In multivariable analysis, baseline hypertension (hazard ratio [HR], 1.30; 95% CI, 1.09-1.55), diabetes (HR, 1.45; 95% CI, 1.17-1.80), smoking (HR, 1.09; 95% CI, 1.01-1.17), apolipoprotein E ε4 genotype (1 allele HR, 1.22; 95% CI, 1.02-1.45; 2 alleles HR, 1.95; 95% CI, 1.35-2.81), and incident stroke (HR, 3.38; 95% CI, 2.78-4.10) and dementia (HR, 2.56; 95% CI, 2.11-3.12) were associated with an increased risk of late-onset epilepsy, while higher levels of physical activity (HR, 0.90; 95% CI, 0.83-0.98) and moderate alcohol intake (HR, 0.72; 95% CI, 0.57-0.90) were associated with a lower risk. Results were similar after censoring individuals with stroke or dementia.
Conclusions and relevance: Potentially modifiable risk factors in midlife and the APOE ε4 genotype were positively associated with risk of developing late-onset epilepsy. Although stroke and dementia were both associated with late-onset epilepsy, vascular and lifestyle risk factors were significant even in the absence of stroke or dementia.
Conflict of interest statement
Figures
Comment in
-
Seize the Day for a Day With No Seizures: Modifiable Midlife Risk Factors Identified.Epilepsy Curr. 2019 Jan;19(1):27-28. doi: 10.1177/1535759718822041. Epub 2019 Jan 30. Epilepsy Curr. 2019. PMID: 30838917 Free PMC article.
Similar articles
-
Seize the Day for a Day With No Seizures: Modifiable Midlife Risk Factors Identified.Epilepsy Curr. 2019 Jan;19(1):27-28. doi: 10.1177/1535759718822041. Epub 2019 Jan 30. Epilepsy Curr. 2019. PMID: 30838917 Free PMC article.
-
Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort.JAMA Neurol. 2017 Oct 1;74(10):1246-1254. doi: 10.1001/jamaneurol.2017.1658. JAMA Neurol. 2017. PMID: 28783817 Free PMC article.
-
Racial Differences in Prevalence and Risk for Intracranial Atherosclerosis in a US Community-Based Population.JAMA Cardiol. 2017 Dec 1;2(12):1341-1348. doi: 10.1001/jamacardio.2017.4041. JAMA Cardiol. 2017. PMID: 29094154 Free PMC article.
-
The relationship between alcohol use and dementia in adults aged more than 60 years: a combined analysis of prospective, individual-participant data from 15 international studies.Addiction. 2023 Mar;118(3):412-424. doi: 10.1111/add.16035. Epub 2022 Sep 4. Addiction. 2023. PMID: 35993434 Free PMC article. Review.
-
Risk factors, ethnicity and dementia: A UK Biobank prospective cohort study of White, South Asian and Black participants.PLoS One. 2022 Oct 12;17(10):e0275309. doi: 10.1371/journal.pone.0275309. eCollection 2022. PLoS One. 2022. PMID: 36223334 Free PMC article. Review.
Cited by
-
Understanding epileptogenesis from molecules to network alteration.Encephalitis. 2024 Jul;4(3):47-54. doi: 10.47936/encephalitis.2024.00038. Epub 2024 Jun 18. Encephalitis. 2024. PMID: 38886161 Free PMC article.
-
Cardiovascular risk factor assessment in late-onset seizures: A study protocol to assess the value of structured intervention.Epilepsia Open. 2024 Aug;9(4):1611-1617. doi: 10.1002/epi4.12987. Epub 2024 Jun 14. Epilepsia Open. 2024. PMID: 38874366 Free PMC article.
-
Excess prevalence of preexisting chronic conditions in older adults with incident epilepsy.Epilepsia. 2024 Aug;65(8):2354-2367. doi: 10.1111/epi.18032. Epub 2024 Jun 4. Epilepsia. 2024. PMID: 38837227
-
Causal relationship between rheumatoid arthritis and epilepsy in a European population: a univariate and multivariate Mendelian randomization study.Front Immunol. 2024 May 16;15:1389549. doi: 10.3389/fimmu.2024.1389549. eCollection 2024. Front Immunol. 2024. PMID: 38817604 Free PMC article.
-
Pathophysiology, Diagnosis, Prognosis, and Prevention of Poststroke Epilepsy: Clinical and Research Implications.Neurology. 2024 Jun 11;102(11):e209450. doi: 10.1212/WNL.0000000000209450. Epub 2024 May 17. Neurology. 2024. PMID: 38759128 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- U01 HL096812/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- U01 HL096917/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- U01 HL096902/HL/NHLBI NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- U01 HL096899/HL/NHLBI NIH HHS/United States
- K24 AG052573/AG/NIA NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
